Logo image of CGD.CA

CARLIN GOLD CORPORATION (CGD.CA) Stock Fundamental Analysis

TSX-V:CGD - TSX Venture Exchange - CA1422402091 - Common Stock - Currency: CAD

0.195  +0.02 (+11.43%)

Fundamental Rating

3

CGD gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 805 industry peers in the Metals & Mining industry. CGD has a great financial health rating, but its profitability evaluates not so good. CGD does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year CGD was profitable.
CGD had a negative operating cash flow in the past year.
CGD.CA Yearly Net Income VS EBIT VS OCF VS FCFCGD.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 200K -200K 400K

1.2 Ratios

CGD's Return On Assets of -3.91% is fine compared to the rest of the industry. CGD outperforms 74.53% of its industry peers.
CGD has a better Return On Equity (-3.95%) than 77.02% of its industry peers.
Industry RankSector Rank
ROA -3.91%
ROE -3.95%
ROIC N/A
ROA(3y)7.89%
ROA(5y)N/A
ROE(3y)9.61%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CGD.CA Yearly ROA, ROE, ROICCGD.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 5 -5 10 15

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CGD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CGD.CA Yearly Profit, Operating, Gross MarginsCGD.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024

More info and screens

9

2. Health

2.1 Basic Checks

Compared to 1 year ago, CGD has about the same amount of shares outstanding.
There is no outstanding debt for CGD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CGD.CA Yearly Shares OutstandingCGD.CA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M
CGD.CA Yearly Total Debt VS Total AssetsCGD.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 1M 2M 3M

2.2 Solvency

CGD has an Altman-Z score of 49.27. This indicates that CGD is financially healthy and has little risk of bankruptcy at the moment.
CGD's Altman-Z score of 49.27 is amongst the best of the industry. CGD outperforms 87.58% of its industry peers.
There is no outstanding debt for CGD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 49.27
ROIC/WACCN/A
WACCN/A
CGD.CA Yearly LT Debt VS Equity VS FCFCGD.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 1M 2M 3M

2.3 Liquidity

CGD has a Current Ratio of 42.50. This indicates that CGD is financially healthy and has no problem in meeting its short term obligations.
CGD has a better Current ratio (42.50) than 96.89% of its industry peers.
A Quick Ratio of 42.50 indicates that CGD has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 42.50, CGD belongs to the best of the industry, outperforming 96.89% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 42.5
Quick Ratio 42.5
CGD.CA Yearly Current Assets VS Current LiabilitesCGD.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 500K 1M 1.5M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for CGD have decreased strongly by -76.56% in the last year.
EPS 1Y (TTM)-76.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%497.78%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 19.50 indicates a rather expensive valuation of CGD.
Based on the Price/Earnings ratio, CGD is valued cheaper than 90.43% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.48. CGD is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 19.5
Fwd PE N/A
CGD.CA Price Earnings VS Forward Price EarningsCGD.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CGD.CA Per share dataCGD.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 0.1 0.15 0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CGD!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CARLIN GOLD CORPORATION

TSX-V:CGD (7/9/2025, 7:00:00 PM)

0.195

+0.02 (+11.43%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners32.42%
Ins Owner ChangeN/A
Market Cap3.62M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 19.5
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.92
P/tB 0.92
EV/EBITDA N/A
EPS(TTM)0.01
EY5.13%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.02
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.21
TBVpS0.21
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.91%
ROE -3.95%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)7.89%
ROA(5y)N/A
ROE(3y)9.61%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 42.5
Quick Ratio 42.5
Altman-Z 49.27
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-76.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%497.78%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-38.23%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y9.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y48.39%
OCF growth 3YN/A
OCF growth 5YN/A